Strong growth in the healthcare industry calls
for equally strong growth in life sciences.
Southern California is home to many
healthcare facilities which provides
opportunities for local life science firms to be
at the forefront of research and development.
Investors understand there is strong synergy in
the market between healthcare and life
science firms which illustrates how integrated
the ecosystem is in Southern California. Recent
significant investment rounds include Dexcom
($350M), Human Longevity ($220M), Endologix
($170M), Biosynthetic Technologies ($100M),
Kernel ($100M), and Puma Biotechnology
($100M).
Capital funding for med-tech industry
35
$500
$450
30
$400
25
$350
$300
20
$250
15
$200
$150
10
$100
5
$50
$0
Funding volume
Source: JLL Research, PWC Moneytree
# of deals
0